| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.43▲ | 0.43▲ | 0.43▲ | 0.43▼ | 0.51▼ |
| MA10 | 0.43▲ | 0.44▲ | 0.44▼ | 0.51▼ | 0.69▼ |
| MA20 | 0.44▲ | 0.44▼ | 0.44▼ | 0.54▼ | 0.93▼ |
| MA50 | 0.44▼ | 0.44▼ | 0.45▼ | 0.72▼ | 1.47▼ |
| MA100 | 0.44▼ | 0.49▼ | 0.59▼ | 0.96▼ | 2.20▼ |
| MA200 | 0.45▼ | 0.57▼ | 0.47▼ | 1.34▼ | 7.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | 0.002▲ | -0.008▼ | -0.031▼ |
| RSI | 49.305▼ | 47.693▼ | 44.000▼ | 41.270▼ | 37.352▼ |
| STOCH | 32.100 | 25.207 | 33.995 | 4.878▼ | 16.464▼ |
| WILL %R | -55.422 | -55.422 | -55.422 | -94.595▼ | -86.957▼ |
| CCI | -0.993 | -56.339 | -60.236 | -60.109 | -80.513 |
|
Monday, June 08, 2026 06:03 AM
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
|
|
Tuesday, April 28, 2026 05:00 PM
On April 28, 2026, Soligenix, Inc. (NASDAQ: SNGX) announced interim results from the Phase 3 FLASH2 of HyBryte™ (SGX301 or synthetic hypericin) in the treatment of cutaneous T cell lymphoma (CTCL).
|
|
Wednesday, March 25, 2026 05:00 PM
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/06/26 | 0.4303 | 0.4458 | 0.4271 | 0.43 | 799,547 |
| 11/06/26 | 0.4321 | 0.4497 | 0.429 | 0.431 | 707,514 |
| 10/06/26 | 0.4204 | 0.458 | 0.42 | 0.4576 | 1,375,263 |
| 09/06/26 | 0.413 | 0.4483 | 0.413 | 0.427 | 1,401,053 |
| 08/06/26 | 0.4481 | 0.473 | 0.4218 | 0.4225 | 13,751,564 |
| 05/06/26 | 0.47 | 0.475 | 0.41 | 0.4433 | 1,413,708 |
| 04/06/26 | 0.496 | 0.5214 | 0.47 | 0.4809 | 2,708,122 |
| 03/06/26 | 0.60 | 0.6217 | 0.455 | 0.4831 | 6,524,287 |
| 02/06/26 | 0.76 | 0.8064 | 0.7323 | 0.7488 | 4,369,006 |
| 01/06/26 | 0.88 | 0.8945 | 0.7801 | 0.8253 | 5,505,263 |
|
|
||||
|
|
||||
|
|